Compared to those in the medium and high dose Exo-rBMMSC groups, AST and ALT expression levels in the liver cirrhosis group were markedly increased; in contrast, ALB was markedly decreased (Figure 5N–P, * p < 0.05). The gene discussed is GPT; the disease is cirrhosis of liver.